Headlines

US FDA halts approval for Pfizer’s trastuzumab biosimilar

24-Apr-2018 By Flora Southey

The US FDA has issued Pifzer a complete response letter for its proposed biosimilar version of Roche’s cancer drug Herceptin.

INTERPHEX 2018

MilliporeSigma looks beyond ‘burn and bury’ for single-use recycling

24-Apr-2018 By Flora Southey

MilliporeSigma is urging industry to recycle single-use technologies, which can be made into speed pumps, parking bollards, and plastic palettes.

Sanofi using Berkeley Lights’ tech to catalyze cell line development

20-Apr-2018 By Melissa Fassbender

Berkeley Lights has signed a new agreement with Sanofi through which the company will use its Beacon OptoFluidic Platform to fast-track cell line development.

Shire turns down Takeda, Allergan toys with buy

20-Apr-2018 By Flora Southey

Shire has rejected Takeda’s acquisition proposals saying the offers ‘undervalue’ its pipeline and potential for growth.

INTERPHEX 2018

MilliporeSigma ups single-use mixer volume to 3,000L

20-Apr-2018 By Flora Southey

MilliporeSigma has launched a new Mobius Power MIX single-use mixing system for buffers, cell culture media powders, and ingredients.

Selexis says $2m investment will speed up cell bank delivery time

19-Apr-2018 By Flora Southey

Cell line developer Selexis has invested in laboratory equipment to reduce delivery times of its high expressing and stable research cell banks.

Pall and Artesyn Biosolutions team to industrialize single-use tech

18-Apr-2018 By Melissa Fassbender

Pall Corporation and Artesyn Biosolutions will co-develop clinical to commercial-scale solutions for single-use automated bioprocessing systems.

Shire sells cancer biz for $2.4bn

17-Apr-2018 By Flora Southey

Shire has sold its oncology business to French firm Servier S.A.S as it looks to better align its long-term strategy.

GE launches modular bioprocessing facility for viral vector vaccines

17-Apr-2018 By Flora Southey

GE Healthcare Life Sciences has launched a prefabricated, modular bioprocessing facility designed for the manufacture of viral vector-based therapeutics.

Alexion to pay $855m for Swedish biotech with Ph III candidate

16-Apr-2018 By Flora Southey

Alexion Pharmaceuticals has announced plans to buy Wilson Therapeutics and its lead candidate WTX101, which has received Fast Track designation.

Bio-Separation: Our outgoing editor looks back over 5 years

13-Apr-2018 By Dan Stanton

Biopharma-Reporter editor Dan Stanton is finally packing his buffer bag and moving upstream.

Sanofi: €350m vaccine investment part of ‘digital factory’ ambition

13-Apr-2018 By Dan Stanton

A new vaccine manufacturing facility in Toronto, Canada will boast single-use tech and closed continuous process to help improve productivity and performance, Sanofi says.